JPH1052487A - Member for medical vessel and equipment - Google Patents
Member for medical vessel and equipmentInfo
- Publication number
- JPH1052487A JPH1052487A JP8210656A JP21065696A JPH1052487A JP H1052487 A JPH1052487 A JP H1052487A JP 8210656 A JP8210656 A JP 8210656A JP 21065696 A JP21065696 A JP 21065696A JP H1052487 A JPH1052487 A JP H1052487A
- Authority
- JP
- Japan
- Prior art keywords
- polypropylene
- polyvinyl chloride
- molding
- molded article
- steam sterilization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Materials For Medical Uses (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Laminated Bodies (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、血液関係、医薬液
関係等の医療分野において使用される医療容器・器具用
部材に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a member for medical containers and instruments used in the medical fields such as blood and medical fluids.
【0002】[0002]
【従来の技術】採血、輸血や輸液をはじめ、医療分野に
おいて用いられるプラスチック製の容器や器具には安全
性、衛生性の他に種々の性能が要求される。ポリ塩化ビ
ニルは可塑剤の量を調節することによって、剛性、柔軟
性、透明性、耐熱性(耐滅菌性)などをコントロールで
きるので、バッグ、チューブ、ジョイント、バッグに設
けられる排出口など、従来から医療分野に広く利用され
ているが、廃棄処理などにおいて問題を生じることがあ
り、エチレン主成分ポリマー、ポリプロピレン主成分ポ
リマーなどの塩素を含有しないポリオレフィン系ポリマ
ーへの移行が進んでいる。2. Description of the Related Art Plastic containers and instruments used in the medical field, including blood collection, blood transfusion and infusion, are required to have various performances in addition to safety and hygiene. By controlling the amount of plasticizer, the rigidity, flexibility, transparency, heat resistance (sterilization resistance), etc. of polyvinyl chloride can be controlled. Conventionally, bags, tubes, joints, outlets provided in bags, etc. Although it is widely used in the medical field, it may cause problems in disposal treatment and the like, and the shift to a chlorine-free polyolefin-based polymer such as an ethylene-based polymer and a polypropylene-based polymer has been progressing.
【0003】しかしながら、ポリオレフィン系ポリマー
では、剛性、柔軟性、透明性、耐熱性などの幅が狭いた
め、ポリ塩化ビニルの使われている領域をカバーできな
いのが現状である。例えば、チューブ、ジョイント、排
出口などではポリ塩化ビニルに代わり得るポリオレフィ
ン材料がないことがあり、結局はポリ塩化ビニルに頼ら
ざるを得ないことが多い。従って現在のところ、ポリオ
レフィン化できる部材はできるだけポリオレフィン化
し、ポリ塩化ビニル製の部分を極力減らすということに
重点が置かれている。[0003] However, polyolefin-based polymers have a narrow range of rigidity, flexibility, transparency, heat resistance and the like, so that at present, it is not possible to cover a region where polyvinyl chloride is used. For example, tubes, joints, outlets, and the like may not have a polyolefin material that can replace polyvinyl chloride, and ultimately must rely on polyvinyl chloride. Therefore, at present, emphasis has been placed on converting polyolefin into members that can be converted into polyolefin as much as possible, and reducing parts made of polyvinyl chloride as much as possible.
【0004】この場合問題になるのは、親和性に乏しい
ポリマー成形品(部材)の接合である。すなわち、ポリ
塩化ビニルとポリオレフィンは通常、接着や融着するこ
とができないため、その展開が大幅に制限されることに
なるからである。ポリエチレンやポリプロピレンにカル
ボキシル基やエポキシ基などを導入した接着性ポリマー
をポリ塩化ビニル製部材とポリオレフィン部材との間に
介在させる構成も提案されているが、十分な接着効果を
発揮しないのが実状である。In this case, the problem is the joining of polymer molded articles (members) having poor affinity. That is, since polyvinyl chloride and polyolefin cannot usually be bonded or fused, their development is greatly restricted. A configuration in which an adhesive polymer in which a carboxyl group or an epoxy group is introduced into polyethylene or polypropylene is interposed between a polyvinyl chloride member and a polyolefin member has been proposed, but in reality, it does not exhibit a sufficient adhesive effect. is there.
【0005】[0005]
【発明が解決しようとする課題】上記問題を鑑み、本発
明はポリオレフィンの中のポリプロピレンからなる成形
品とポリ塩化ビニルからなる成形品とを一体化(接着)
した医療容器・器具用部材を提供することにある。In view of the above problems, the present invention integrates (adheses) a molded article made of polypropylene and a molded article made of polyvinyl chloride in polyolefin.
To provide a medical container / instrument member.
【0006】[0006]
【課題を解決するための手段】本発明は塩素化ポリプロ
ピレンを介して、ポリ塩化ビニル系成形品とポリプロピ
レン系成形品とが接着されてなる医療容器・器具用部材
であり、前記塩素化ポリプロピレンが前記ポリ塩化ビニ
ル系成形品と前記ポリプロピレン系成形品のいずれに対
しても良好な親和性を有し、医療分野で通常に行われる
高圧蒸気滅菌処理においても接着力が保たれて、かつ安
全性、衛生性にも優れていることを特徴とする。SUMMARY OF THE INVENTION The present invention is a medical container / tool member in which a polyvinyl chloride-based molded article and a polypropylene-based molded article are adhered to each other via a chlorinated polypropylene. It has a good affinity for both the polyvinyl chloride-based molded article and the polypropylene-based molded article, and the adhesive strength is maintained even in the high-pressure steam sterilization treatment usually performed in the medical field, and the safety is maintained. It is also characterized by excellent hygiene.
【0007】[0007]
【発明の実施の形態】本発明において塩素化ポリプロピ
レン(以下、Cl−PPと称す)は、ポリプロピレンを
通常公知の方法で塩素化して得られるものであり、タイ
プとしてはアイソタクチックポリプロピレン、シンジオ
タクチックポリプロピレン及びアタクチックポリプロピ
レンを塩素化したものが挙げられるがアイソタクチック
のものが一般的である。本発明の趣旨であるポリ塩化ビ
ニル(以下、PVCと称す)系成形品とポリプロピレン
(以下、PPと称す)系成形品との接着性を考慮する
と、Cl−PPの塩素量は15〜50重量%が好まし
い。一般的には塩素量が多い程PVC系成形品への接着
性に優れ、少ない領域ではPP系成形品への接着性に優
れる。PVC系成形品やPP系成形品への種類、性状等
によって適宣Cl−PP中の塩素量を調節することが可
能であるが、20〜40重量%の塩素量がさらに好まし
い範囲である。また、Cl−PPの分子量、分子量分布
などの特性を表す指標として溶液粘度があるが、本発明
においてはトルエン溶液(Cl−PP濃度10重量%)
の25℃における粘度が50〜500センチポイズ、さ
らに好ましくは100〜400センチポイズのものが接
着力という点で適当である。BEST MODE FOR CARRYING OUT THE INVENTION Chlorinated polypropylene (hereinafter referred to as Cl-PP) in the present invention is obtained by chlorinating polypropylene by a generally known method, and is classified into isotactic polypropylene and syndiotactic polypropylene. Examples include chlorinated tic polypropylene and atactic polypropylene, but isotactic ones are generally used. In consideration of the adhesiveness between a polyvinyl chloride (hereinafter, referred to as PVC) -based molded article and a polypropylene (hereinafter, referred to as PP) -based molded article, which is the gist of the present invention, the chlorine amount of Cl-PP is 15 to 50% by weight. % Is preferred. In general, the greater the chlorine content, the better the adhesion to the PVC-based molded article, and the smaller the area, the more excellent the adhesion to the PP-based molded article. Although the amount of chlorine in Cl-PP can be appropriately adjusted depending on the type, properties, etc. of the PVC-based or PP-based molded product, a chlorine content of 20 to 40% by weight is a more preferable range. Further, there is a solution viscosity as an index indicating characteristics such as a molecular weight and a molecular weight distribution of Cl-PP, but in the present invention, a toluene solution (Cl-PP concentration of 10% by weight)
A viscosity at 25 ° C. of 50 to 500 centipoise, more preferably 100 to 400 centipoise, is suitable from the viewpoint of adhesive strength.
【0008】本発明においてPVC系成形品は数平均重
合度700〜5000の塩化ビニル主成分ポリマーに、
ジ−2−エチルヘキシルフタレート、ジ−n−デシルフ
タレート、トリ−2−エチルヘキシルトリメリテート、
ジ−2−エチルヘキシルアジペート、ジ−2−エチルヘ
キシルセバケート、ブチリルトリ−n−ヘキシルシトレ
ート、アジピン酸系ポリエステル、エポキシ化大豆油な
どの可塑剤を5〜70重量%配合した成形品が通常であ
るが、エチレン酢酸ビニルコポリマー変性ポリ塩化ビニ
ル、ポリウレタン変性ポリ塩化ビニル、架橋型ポリ塩化
ビニルであっても良い。[0008] In the present invention, the PVC molded article is a vinyl chloride-based polymer having a number average degree of polymerization of 700 to 5000,
Di-2-ethylhexyl phthalate, di-n-decyl phthalate, tri-2-ethylhexyl trimellitate,
Molded articles containing 5 to 70% by weight of a plasticizer such as di-2-ethylhexyl adipate, di-2-ethylhexyl sebacate, butyryltri-n-hexyl citrate, adipic acid-based polyester, and epoxidized soybean oil are usually used. May be ethylene vinyl acetate copolymer-modified polyvinyl chloride, polyurethane-modified polyvinyl chloride, or cross-linked polyvinyl chloride.
【0009】本発明においてPP系成形品はアイソタク
チックタイプもしくはシンジオタクチックタイプの結晶
性ポリプロピレンまたはこれらを主成分とする結晶性コ
ポリマーからなる成形品であり、PPはその成形性、力
学的性質などを考慮すると温度230℃、荷重2160
gにおけるメルトフローレイト(MFR)が0.3〜5
0、より好ましくは0.5〜30であるのが良い。場合
によっては、成形品に要求される性能に応じて他のポリ
マー、例えばポリエチレン、ポリブテン−1、スチレン
系熱可塑性エラストマー、オレフィン系熱可塑性エラス
トマーなどを配合しても良い。In the present invention, the PP-based molded article is a molded article made of an isotactic or syndiotactic type crystalline polypropylene or a crystalline copolymer containing these as a main component, and PP is its moldability and mechanical properties. Considering such factors as temperature 230 ° C and load 2160
The melt flow rate (MFR) in g is 0.3 to 5
0, more preferably 0.5 to 30. In some cases, other polymers such as polyethylene, polybutene-1, a styrene-based thermoplastic elastomer, an olefin-based thermoplastic elastomer, and the like may be blended according to the performance required for the molded article.
【0010】PVC系成形品あるいはPP系成形品は、
シート、フィルム、バッグ、チューブ、ジョイントなど
の種々の形態をなすが、これらは通常公知の押出成形
(インフレ、ブロー、Tダイなど)や射出成形で製造さ
れる。PVC系成形品およびPP系成形品を得る時の成
形時の溶融温度はそれぞれ140〜200℃、および1
70〜230℃であるのが良い。[0010] PVC-based molded products or PP-based molded products are:
Various forms such as a sheet, a film, a bag, a tube, and a joint are formed, and these are usually manufactured by known extrusion molding (inflation, blow, T-die, etc.) or injection molding. The melting temperatures at the time of molding to obtain a PVC molded article and a PP molded article are 140 to 200 ° C. and 1 respectively.
The temperature is preferably 70 to 230 ° C.
【0011】また、接着の役目を果たすCl−PPも同
様であり、一般的には80〜120℃程度の温度で成形
され得る。場合によっては、有機溶剤、例えばトルエ
ン、キシレン、メチルエチルケトン、メチルイソブチル
ケトン、酢酸エチル、酢酸ブチル、テトラヒドロフラン
などに溶解し、溶液の形でPVC系成形品やPP系成形
品に塗布する形で供しても良い。接着温度は50〜13
0℃程度が良く、高圧蒸気滅菌時あるいはガス滅菌時の
熱を利用することもできる。The same applies to Cl-PP which plays a role of adhesion, and can be generally formed at a temperature of about 80 to 120 ° C. In some cases, it is dissolved in an organic solvent, for example, toluene, xylene, methyl ethyl ketone, methyl isobutyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, etc., and provided in the form of a solution to be applied to a PVC molded article or a PP molded article. Is also good. Adhesion temperature is 50-13
The temperature is preferably about 0 ° C., and heat during high-pressure steam sterilization or gas sterilization can be used.
【0012】[0012]
【実施例】以下、実施例を示し、本発明をさらに詳細に
説明する。 (方法) 以下の通りのCl−PP(A1及びA2)、PVC系成
形品(B1及びB2)およびPP系成形品(C1及びC2)
を準備した。 A1:塩素含有率20%、10%トルエン溶液粘度10
0センチポイズのCl−PPのペレットを120℃でプ
レス成形して得た厚さ50μmのフィルム。 A2:塩素含有率35%、10%トルエン溶液粘度15
0センチポイズのCl−PPのペレットを100℃でプ
レス成形して得た厚さ70μmのフィルム。 B1:数平均重合度1500のPVCにジ−2−エチル
ヘキシルフタレート10重量%を加えて得たコンパウン
ドを射出成形して得た図1に示す通常の輸液バッグ等に
設けられる排出口形状の成形品。 B2:数平均重合度2500のPVCにジ−n−デシル
フタレート40重量%を加えて得たコンパウンドをイン
フレ成形して得たシート(厚さ300μm、折径150
mm)を図2に示す通常の輸液バッグ等の形状に製袋し
た成形品。 C1:MFR8.2のアイソタクチックタイプのPPコポ
リマーのペレットを射出成形して得た成形品。形状はB
1と同様の排出口形状。 C2:MFR2.1のアイソタクチックタイプのPPコポ
リマーのペレットをインフレ成形して得たシート(厚さ
300μm、折径150mm)を図2に示す通常の輸液
バッグ等の形状に製袋した成形品。The present invention will be described in more detail with reference to the following examples. (Method) as follows the Cl-PP (A 1 and A 2), PVC-based molded product (B 1 and B 2) and PP-based molded article (C 1 and C 2)
Was prepared. A 1 : 20% chlorine content, 10% toluene solution viscosity 10
A 50-μm-thick film obtained by press-forming a 0-centipoise Cl-PP pellet at 120 ° C. A 2 : 35% chlorine content, 10% toluene solution viscosity 15
A 70 μm thick film obtained by press-forming a 0-centipoise Cl-PP pellet at 100 ° C. B 1 : Molding of the shape of an outlet provided in a usual infusion bag or the like shown in FIG. 1 obtained by injection molding a compound obtained by adding 10% by weight of di-2-ethylhexyl phthalate to PVC having a number average polymerization degree of 1500. Goods. B 2 : A sheet obtained by inflation molding a compound obtained by adding 40% by weight of di-n-decyl phthalate to PVC having a number average degree of polymerization of 2500 (thickness: 300 μm, folding diameter: 150)
mm) in the form of a normal infusion bag or the like shown in FIG. C 1 : A molded product obtained by injection molding pellets of an isotactic type PP copolymer of MFR 8.2. Shape is B
Outlet shape similar to 1 . C 2 : A sheet (thickness: 300 μm, folded diameter: 150 mm) obtained by inflation molding pellets of an isotactic type PP copolymer having MFR of 2.1 into a shape such as a normal infusion bag shown in FIG. Goods.
【0013】容器の作製 上記のA1、A2を裁断して、排出口B1、C1の根元部に
巻き付け、その部分のみを図1の取り付け部分4に差し
込み、金型で挟んで温度100℃、圧力2kg/c
m2、時間10秒の条件で排出口を取り付けた。以下、
その時の組み合わせを示す。 実施例1:排出口 B1、接着フィルム A1、袋 B2 実施例2:排出口 B1、接着フィルム A2、袋 C2 実施例3:排出口 C1、接着フィルム A1、袋 B2 実施例4:排出口 C1、接着フィルム A2、袋 C2 Preparation of Container The above-mentioned A 1 and A 2 are cut and wrapped around the roots of the discharge ports B 1 and C 1 , and only that part is inserted into the mounting part 4 in FIG. 100 ° C, pressure 2kg / c
The outlet was attached under the conditions of m 2 and time of 10 seconds. Less than,
The combination at that time is shown. Example 1: Discharge port B 1 , adhesive film A 1 , bag B 2 Example 2: Discharge port B 1 , adhesive film A 2 , bag C 2 Example 3: Discharge port C 1 , adhesive film A 1 , bag B 2 Example 4: Outlet C 1 , adhesive film A 2 , bag C 2
【0014】高圧蒸気滅菌 上記の各容器(実施例)に生理食塩水500mlを入
れ、排出口の上部に、輸液用ゴム栓を装着したキャップ
(キャップの材質は排出口と同じ物を使用。すなわち、
排出口がB1の時キャップはPVC、C1の時キャップは
PPである。)を被せ、超音波シール法でキャップと排
出口を融着した。次いで、この薬液入り容器を高圧蒸気
滅菌機に入れ、温度110℃、ゲージ圧1.8kg/c
m2、時間30分の条件で滅菌処理し、室温まで冷却し
た。High-pressure steam sterilization 500 ml of physiological saline is put into each of the above-mentioned containers (examples), and a cap provided with a rubber stopper for infusion above the outlet (the cap is made of the same material as the outlet. ,
Cap when the outlet B 1 represents PVC, cap when C 1 is PP. ), And the cap and the outlet were fused by an ultrasonic sealing method. Next, the container with the drug solution was put into a high-pressure steam sterilizer, and the temperature was 110 ° C. and the gauge pressure was 1.8 kg / c.
The solution was sterilized under the conditions of m 2 and 30 minutes, and cooled to room temperature.
【0015】評価 各実施例において、上記の滅菌処理を10容器につい
て行い、滅菌・冷却処理後の排出口/接着フィルム(A
1またはA2)/袋の間の密着状態と内部薬液の漏れ状態
を観察した。Evaluation In each example, the above sterilization treatment was performed on 10 containers, and the outlet / adhesive film (A
1 or A 2 ) / The close contact state between the bags and the leakage state of the internal chemical solution were observed.
【0016】(結果) 滅菌前後において、排出口と接着フィルムの間、接
着フィルムと袋の間の外観変化はほとんどなく、良好な
状態で接着されていた。また、内容液の漏れは全くなか
った。 また、日本薬局方(第13改正)一般試験法「プラ
スチック製医薬品容器試験法」に準じ、各実施例の原料
ペレットについて重金属および溶出物試験を行ったとこ
ろ、いずれも適合することが確認された。(Results) Before and after sterilization, there was almost no change in the appearance between the discharge port and the adhesive film, and between the adhesive film and the bag. Also, there was no leakage of the content liquid. In addition, according to the Japanese Pharmacopoeia (13th revision) general test method “Plastic drug container test method”, the raw material pellets of each example were subjected to heavy metal and dissolution test, and it was confirmed that both were compatible. .
【0017】(比較例)接着フィルムA1、A2の代わり
に厚さ70μmの酸無水物変性ポリオレフィンフィルム
を用いて、実施例1、2と同様の実験を行ったが、いず
れもPVC系成形品(B1またはB2)と酸無水物変性ポ
リオレフィンフィルムとの間は全く接着せず、高圧蒸気
滅菌実験(上記、方法−)の段階には至らなかった。(Comparative Example) The same experiment as in Examples 1 and 2 was performed using an acid anhydride-modified polyolefin film having a thickness of 70 μm instead of the adhesive films A 1 and A 2. There was no adhesion between the product (B 1 or B 2 ) and the acid anhydride-modified polyolefin film, and the stage of the high-pressure steam sterilization experiment (the above-mentioned method-) was not reached.
【0018】[0018]
【発明の効果】以上記載した如く、本発明の医療容器・
器具用部材は、塩素化ポリプロピレンを介して、ポリ塩
化ビニル系成形品とポリプロピレン系成形品とが接着さ
れており、高圧蒸気滅菌時にも当該接着部分の接着力が
弱まることがない。従って、高圧蒸気滅菌に耐えられ、
医療容器・器具用部材の機密性、液密性が保てるため
に、安全性、衛生性にも優れている。As described above, the medical container of the present invention
In the member for instruments, the polyvinyl chloride-based molded article and the polypropylene-based molded article are adhered via the chlorinated polypropylene, and the adhesive strength of the adhered portion is not weakened even during high-pressure steam sterilization. Therefore, it can withstand high pressure steam sterilization,
Since the confidentiality and liquid tightness of the medical container / instrument members can be maintained, they are also excellent in safety and hygiene.
【図1】 実施例にて作製した通常の輸液バッグ等に設
けられる排出口形状の成形品の縦断面図を示す。FIG. 1 is a longitudinal sectional view of a molded product having a discharge port shape provided in a normal infusion bag or the like manufactured in an example.
【図2】 実施例にて作製した通常の輸液バッグ等の形
状に製袋した成形品の外観図を示す。FIG. 2 is an external view of a molded product formed into a shape such as a normal infusion bag or the like manufactured in an example.
【符号の説明】 1・・・成形品、2・・・シール部、3・・・シール部、4・・・取
り付け部[Explanation of Signs] 1 ... Molded product, 2 ... Seal part, 3 ... Seal part, 4 ... Mounting part
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 B32B 27/30 101 C08J 5/12 CES C08J 5/12 CES CEV CEV A61J 1/00 331A ──────────────────────────────────────────────────の Continuation of the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location B32B 27/30 101 C08J 5/12 CES C08J 5/12 CES CEV CEV A61J 1/00 331A
Claims (2)
ビニル系成形品とポリプロピレン系成形品とが接着され
てなる医療容器・器具用部材。1. A member for a medical container or device in which a polyvinyl chloride-based molded article and a polypropylene-based molded article are adhered via chlorinated polypropylene.
5〜50重量%であることを特徴とする請求項1記載の
医療容器・器具用部材。2. The chlorinated polypropylene has an amount of chlorine of 1
The member for medical containers and instruments according to claim 1, wherein the content is 5 to 50% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8210656A JPH1052487A (en) | 1996-08-09 | 1996-08-09 | Member for medical vessel and equipment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8210656A JPH1052487A (en) | 1996-08-09 | 1996-08-09 | Member for medical vessel and equipment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH1052487A true JPH1052487A (en) | 1998-02-24 |
Family
ID=16592931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8210656A Pending JPH1052487A (en) | 1996-08-09 | 1996-08-09 | Member for medical vessel and equipment |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH1052487A (en) |
-
1996
- 1996-08-09 JP JP8210656A patent/JPH1052487A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4516977A (en) | Storage bag | |
| US5928744A (en) | PVC-free multilayer tube for medical purposes, process for the production thereof and use | |
| CA1189027A (en) | Bag for the storage of liquids | |
| US5533992A (en) | Material for medical grade products and products made therefrom | |
| KR100439410B1 (en) | Multilayer foil, its manufacturing method and use | |
| US4528220A (en) | Plastic bags for medical solutions and blood | |
| CA2431989C (en) | Port tube and closure composition, structure and assembly for a flowable material container | |
| JP5722538B2 (en) | Retortable composition | |
| US5486387A (en) | Impact modified medical film | |
| JPH021278A (en) | medical packaging unit | |
| JPH0553510B2 (en) | ||
| JP2505476B2 (en) | Chemically stabilized film | |
| JPH09262948A (en) | Resin laminate and its use | |
| JPS62156153A (en) | Polymer composition | |
| EP2134544A1 (en) | Non-pvc system tube for biomedical | |
| EP0980892A1 (en) | Molded product for medical use from a resin composition comprising a polyolefin resin and a specific block terpolymer | |
| JPH0975444A (en) | Medical base material | |
| JP3692516B2 (en) | Resin composition, easily peelable film formed using the same, and flexible container | |
| CA1205783A (en) | Storage bag | |
| JPH10263072A (en) | Member for medical instrument and medical instrument | |
| JPH0999036A (en) | Vessel for medical treatment | |
| JPS63214260A (en) | Soft medical bag | |
| JPH02227251A (en) | Transfusion bag | |
| JPH1016053A (en) | Medical equipment and its manufacture | |
| JP4906159B2 (en) | Laminated body and medical bag |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040630 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050802 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060131 |